K-numberK240775
Device namePeriBeam® Pericardial Membrane
ApplicantTamabio
Product codeDXZ
Device classClass II
Decision dateApr 18, 2025
DecisionSubstantially Equivalent
Regulation870.3470
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

PeriBeam® Pericardial Membrane is an ion-irradiated, expanded polytetrafluoroethylene (ePTFE) membrane used for reconstruction or repair of the pericardium. It functions as a temporary or permanent prosthesis to cover pericardial defects and is held in place by surgical sutures.

Technological characteristics

Both PeriBeam® and the predicate PRECLUDE® Pericardial Membrane are made of ePTFE with nearly identical technological characteristics. The key difference is that PeriBeam® features ion-beam etching on one surface designed to create an adhesive surface for the pericardium, whereas the predicate lacks this modification. Materials, dimensions, thickness, sterilization method, packaging, and biological safety are otherwise similar.

Test standards cited

ISO 2859-1 (tensile and suture strength), ISO 13938-1 (burst strength), JIS L1096 8.18 (burst strength equivalent), ISO 10993 (cytotoxicity, sensitization, irritation, acute systemic toxicity, pyrogenicity, subacute toxicity, implantation, genotoxicity, chronic toxicity, carcinogenicity, hemolysis), JIST 0186-1:2010 and ISO 17665-1:2006 (sterilization), ISO 11135, ISO 11737-1, ISO 11607-1:2019, ASTM F1980, ASTM F2096, and ASTM F88 (packaging and shelf-life validation).

Substantial equivalence argument

PeriBeam® is substantially equivalent because it shares the same ePTFE material composition, identical indications for use (pericardial reconstruction/repair), and equivalent performance characteristics as the predicate device. Although ion-beam etching is added to enhance surface adhesion, comprehensive performance testing including tensile strength, suture strength, fatigue, burst strength, and fibrin glue compatibility demonstrates mechanical safety. Animal implantation studies and extensive ISO 10993 biocompatibility testing confirm the modification does not introduce new safety risks, making the device appropriate for the same clinical application as its predicate.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →